EnteroMedics Inc. (RSLS) Posts Quarterly Earnings Results, Misses Expectations By $0.77 EPS

EnteroMedics Inc. (NASDAQ:RSLS) posted its quarterly earnings results on Tuesday. The medical device company reported ($1.06) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.77), Bloomberg Earnings reports. EnteroMedics had a negative net margin of 4,399.48% and a negative return on equity of 167.73%.

EnteroMedics (NASDAQ RSLS) traded down $0.05 during trading hours on Tuesday, hitting $1.65. 217,000 shares of the company were exchanged, compared to its average volume of 1,693,029. EnteroMedics has a 1 year low of $1.47 and a 1 year high of $30.41.

RSLS has been the subject of several analyst reports. Zacks Investment Research cut shares of EnteroMedics from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. ValuEngine raised shares of EnteroMedics from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st.

COPYRIGHT VIOLATION WARNING: “EnteroMedics Inc. (RSLS) Posts Quarterly Earnings Results, Misses Expectations By $0.77 EPS” was first published by Week Herald and is the property of of Week Herald. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://weekherald.com/2017/11/14/enteromedics-inc-rsls-posts-quarterly-earnings-results-misses-expectations-by-0-77-eps.html.

EnteroMedics Company Profile

ReShape Lifesciences Inc, formerly EnteroMedics Inc, is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company’s neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve.

Earnings History for EnteroMedics (NASDAQ:RSLS)

Receive News & Ratings for EnteroMedics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EnteroMedics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply